These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37287599)

  • 21. Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy.
    Ruiz G; Yeaw J; Lickert CA; De AP; Wade RL; Pruett J; Drake W
    J Health Econ Outcomes Res; 2018; 5(2):206-219. PubMed ID: 35620777
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostacyclin Use Among Patients with Pulmonary Arterial Hypertension in the United States: A Retrospective Analysis of a Large Health Care Claims Database.
    Burger CD; Pruett JA; Lickert CA; Berger A; Murphy B; Drake W
    J Manag Care Spec Pharm; 2018 Mar; 24(3):291-302. PubMed ID: 29406840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension.
    Zhang C; Tsang Y; He J; Panjabi S
    Adv Ther; 2023 May; 40(5):2481-2492. PubMed ID: 37024760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare Service Use Patterns Among Patients with Acid Sphingomyelinase Deficiency Type B: A Retrospective US Claims Analysis.
    Pulikottil-Jacob R; Ganz ML; Fournier M; Petruski-Ivleva N
    Adv Ther; 2023 May; 40(5):2234-2248. PubMed ID: 36897522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-World Analysis of Treatment Patterns Among Hospitalized Patients with Pulmonary Arterial Hypertension.
    Ogbomo A; Tsang Y; Kariburyo F; Tsai WL; Panjabi S
    Pulm Ther; 2021 Dec; 7(2):575-590. PubMed ID: 34699029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
    Burger CD; Ozbay AB; Lazarus HM; Riehle E; Montejano LB; Lenhart G; White RJ
    J Manag Care Spec Pharm; 2018 Aug; 24(8):834-842. PubMed ID: 29436260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
    Copher R; Cerulli A; Watkins A; Laura Monsalvo M
    J Med Econ; 2012; 15(5):947-55. PubMed ID: 22554140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database.
    Studer S; Hull M; Pruett J; Koep E; Tsang Y; Drake W
    Pulm Circ; 2019; 9(1):2045894018816294. PubMed ID: 30421652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States.
    Pizzicato LN; Nadipelli VR; Governor S; Mao J; Lanes S; Butler J; Pepe RS; Phatak H; El-Kersh K
    Pulm Circ; 2022 Apr; 12(2):e12090. PubMed ID: 35795495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms.
    Mathai SC; Hemnes AR; Manaker S; Anguiano RH; Dean BB; Saundankar V; Classi P; Nelsen AC; Gordon K; Ventetuolo CE
    Ann Am Thorac Soc; 2019 Jul; 16(7):797-806. PubMed ID: 30865835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burden of pulmonary hypertension in patients with portal hypertension in the United States: a retrospective database study.
    Sahay S; Tsang Y; Flynn M; Agron P; Dufour R
    Pulm Circ; 2020; 10(4):2045894020962917. PubMed ID: 33282188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.
    Bauer Y; de Bernard S; Hickey P; Ballard K; Cruz J; Cornelisse P; Chadha-Boreham H; Distler O; Rosenberg D; Doelberg M; Roux S; Nayler O; Lawrie A
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33334933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension.
    Kiely DG; Doyle O; Drage E; Jenner H; Salvatelli V; Daniels FA; Rigg J; Schmitt C; Samyshkin Y; Lawrie A; Bergemann R
    Pulm Circ; 2019; 9(4):2045894019890549. PubMed ID: 31798836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective claims analysis of fatigue in patients with multiple sclerosis on disease-modifying therapy.
    Leist TP; Cole M; Verma S; Keenan A; Le HH
    Mult Scler Relat Disord; 2023 Oct; 78():104917. PubMed ID: 37597349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost to managed care of managing pulmonary hypertension.
    Said Q; Martin BC; Joish VN; Kreilick C; Mathai SC
    J Med Econ; 2012; 15(3):500-8. PubMed ID: 22313330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Sildenafil in Pulmonary Arterial Hypertension: Findings from a U.S. Healthcare Claims Database.
    Berger A; Edelsberg J; Teal S; Mychaskiw MA; Oster G
    J Health Econ Outcomes Res; 2014; 1(3):254-265. PubMed ID: 34430662
    [No Abstract]   [Full Text] [Related]  

  • 39. Validation of claims-based algorithms for pulmonary arterial hypertension.
    Papani R; Sharma G; Agarwal A; Callahan SJ; Chan WJ; Kuo YF; Shim YM; Mihalek AD; Duarte AG
    Pulm Circ; 2018; 8(2):2045894018759246. PubMed ID: 29480064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.
    Coghlan JG; Denton CP; Grünig E; Bonderman D; Distler O; Khanna D; Müller-Ladner U; Pope JE; Vonk MC; Doelberg M; Chadha-Boreham H; Heinzl H; Rosenberg DM; McLaughlin VV; Seibold JR;
    Ann Rheum Dis; 2014 Jul; 73(7):1340-9. PubMed ID: 23687283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.